Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CONy 2020 | The potential of wearable devices in epilepsy

Andreas Schulze-Bonhage • 29 Oct 2020
CONy 2020
Epilepsy

Andreas Schulze-Bonhage, MD, PhD, University Medical Center Freiburg, Freiburg im Breisgau, Germany, discusses the development of new devices to monitor epilepsy. These new devices enable long-term assessment of epilepsy patients and can be used to improve therapy. They can be used to alarm patients of seizures and gain more information about seizures. The use of these devices will change the field considerably. This interview took place during the Virtual World Congress on Controversies in Neurology (CONy) 2020.

More from Andreas Schulze-Bonhage

Focal cortical stimulation with the EASEE system for pharmacoresistant focal epilepsy
7:51
Focal cortical stimulation with the EASEE system for pharmacoresistant focal epilepsy
Andreas Schulze-Bonhage • 13 Sep 2024
Responsive neuromodulation for epilepsy: reducing exposition time to stimulation
2:41
Responsive neuromodulation for epilepsy: reducing exposition time to stimulation
Andreas Schulze-Bonhage • 13 Sep 2024
Intrinsic and extrinsic factors affecting seizure propensity
5:44
Intrinsic and extrinsic factors affecting seizure propensity
Andreas Schulze-Bonhage • 29 Jun 2022
Advances in wearable devices and their integration into patient care for epilepsy
1:31
Advances in wearable devices and their integration into patient care for epilepsy
Andreas Schulze-Bonhage • 29 Jun 2022

Related Videos

Which emerging epilepsy therapies are likely to change clinical practice?
9:12
Which emerging epilepsy therapies are likely to change clinical practice?
William Alves Martins • 20 Oct 2026
Emerging precision therapies reshaping the antiseizure medication landscape in epilepsy
9:58
Emerging precision therapies reshaping the antiseizure medication landscape in epilepsy
William Alves Martins • 20 Oct 2026
Phase II/III POWER1: efficacy, safety and lessons learned for vormatrigine in epilepsy
8:05
Phase II/III POWER1: efficacy, safety and lessons learned for vormatrigine in epilepsy
William Alves Martins • 20 Oct 2026
Emerging gene therapies for Dravet syndrome and other DEEs
10:41
Emerging gene therapies for Dravet syndrome and other DEEs
William Alves Martins • 20 Oct 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals